Loading...
Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion
Introduction: Denosumab, a fully human monoclonal antibody, targets the receptor activator of nuclear factor-kappaB (RANK) ligand, a protein essential for osteoclast differentiation, activity and survival. Loss of osteoclasts from the bone surface reduces bone turnover and bone loss in malignant and...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3169928/ https://ncbi.nlm.nih.gov/pubmed/21957430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834011412656 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|